Form 4: BeiGene Director Anthony C. Hooper Reports Share Acquisition and Option Grant
SEC Form 4 Filing
Director Anthony C. Hooper reports acquisition of ordinary shares and grant of share options in BeiGene, Ltd.
Summary
- On May 21, 2025, Anthony C. Hooper, a director of BeiGene, Ltd., reported acquiring 10,985 ordinary shares.
- These shares were acquired at a price of $0.
- Following the transaction, Hooper beneficially owns 64,740 ordinary shares.
- Hooper was also granted options to purchase 22,750 ordinary shares at an exercise price of $18.19.
- The options become fully exercisable on the earlier of the first anniversary of the grant date or the date of the next annual general meeting.
- Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- The restricted share units and options were granted under the Company's Independent Director Compensation Policy, as amended.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing insider transactions. The acquisition of shares and grant of options could be seen as mildly positive, but it's not a major event.
Positives
- The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
- The grant of share options incentivizes the director to work towards increasing shareholder value.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted share units and options.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their alignment with shareholder interests.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholders if it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction: acquisition of ordinary shares and grant of share options. |
| 05/20/2035 | Expiration date of share options. |
| 05/22/2025 | Date of signature for the Form 4 filing. |
Keywords
BeiGene, Director, Share Acquisition, Option Grant, Anthony C. Hooper, Ordinary Shares, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.